Charles River Laboratories (CRL)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 22,203 423,782 441,514 444,453 474,624 474,950 484,034 496,335 486,226 436,394 443,347 422,474 390,982 396,595 396,078 375,065 364,304 301,461 271,362 247,655
Total assets US$ in thousands 7,528,340 8,003,840 7,948,280 8,152,780 8,195,000 7,607,010 7,772,380 7,699,440 7,602,770 7,382,770 7,529,360 7,075,050 7,024,290 7,058,440 6,720,350 5,808,960 5,490,830 5,213,340 5,240,880 5,201,790
ROA 0.29% 5.29% 5.55% 5.45% 5.79% 6.24% 6.23% 6.45% 6.40% 5.91% 5.89% 5.97% 5.57% 5.62% 5.89% 6.46% 6.63% 5.78% 5.18% 4.76%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $22,203K ÷ $7,528,340K
= 0.29%

The return on assets (ROA) for Charles River Laboratories has shown a generally positive trend from March 2020 to December 2023, fluctuating between 4.76% to 6.45%. This indicates that the company has been efficient in generating profits relative to its total assets during this period.

However, there was a significant drop in ROA to 0.29% by December 2024, which raises concerns about the company's ability to generate profits from its assets effectively. It would be important to further investigate the factors contributing to this sudden decline in ROA to assess the overall financial health and performance of Charles River Laboratories.